Targeted escape of SARS-CoV-2 in vitro from monoclonal antibody S309, the precursor of sotrovimab. - Magnus CL; Hiergeist A; Schuster P; Rohrhofer A; Medenbach J; Gessner A; Peterhoff D; Schmidt B (Frontiers in immunology, 2022)